Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

The Trump transition for healthcare: Who’s leading it, what associations want

As the initial shock of Donald Trump’s surprise victory in the presidential race wears off, his HHS transition team now has a leader and major professional associations are reaching out with policy priorities—which for some groups may include fighting the president-elect’s promise to repeal the Affordable Care Act (ACA).

Thumbnail

How state healthcare initiatives fared on Election Day

Besides the presidential election’s ramifications on the healthcare industry, there were several important ballot initiatives affecting health policy across the country. 

Thumbnail

So long, ACA: What President Trump means for healthcare

Healthcare’s new reality could be a return to pre-Affordable Care Act (ACA) policies and turning Medicaid into a state block grant program after Donald Trump’s upset victory in the 2016 presidential election.

CMS long-term care rule blocked by federal judge

A rule banning nursing homes from requiring residents to sign contracts requiring pre-dispute arbitration has been temporarily blocked by a federal judge.

Recondo Technology Closes $16 million Funding Round to Support Exponential Growth to Power the Healthcare Revenue Cycle

Greenwood Village, CO—November 3, 2016—Recondo Technology, the market leader in cloud-based single-platform revenue cycle management solutions, announced today that it closed an additional $16 million in debt and capital funding to support and accelerate the company’s future growth curve. Lehmi Ventures led the round, with Bridge Capital serving as the debt partner.

Opinion: Marijuana could curb reliance on opioids for pain relief

Esther K. Choo, MD, MPH, and colleagues urge for a universal standing on cannabis as the solution to the opioid epidemic.

New dry-powder asthma inhaler receives FDA clearance

Propeller Health, a producer of digital products for respiratory medication, has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the GSK's Ellipta inhaler and platform, a treatment for asthma featuring a patented dry-powder inhaler.

Opioid poisonings skyrocket in American youths

America is in the grips of an epidemic, this epidemic isn’t driven by a mysterious virus but rather a drug being prescribed every day. Opioid use has increased at an unprecedented rate, leading to addictions and overdoses among the masses, and those effected aren’t limited to adults.

Around the web

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Trimed Popup
Trimed Popup